Boston Scientific acquires Relievant Medsystems for $850M cash for the nerve ablation technology

By

Boston Scientific to acquire nerve ablation tech developer Relievant Medsystems for $850M (MedDevice)
Boston Scientific(NYSE: BSX)+ announced today that it entered into a definitive agreement to acquire Relievant Medsystems.
The transaction includes an upfront cash payment of $850 million. Additional payments are contingent on sales performance over the next three years.
Minneapolis-based Relievant developed and commercialized the Intracept intraosseous nerve ablation system for chronic pain. The minimally invasive, FDA-cleared, same-day, outpatient procedure treats chronic vertebro...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.